DUBLIN--(BUSINESS WIRE)--The "Hereditary Deafness - Market Insight, Competitive Landscape and Market Forecast, 2026" report has been added to ResearchAndMarkets.com's offering.
This report delivers an in-depth understanding of Hereditary Deafness and the historical and forecasted Hereditary Deafness market trends in the US, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Hereditary Deafness market report provides an overview of Hereditary Deafness, its cause, diagnosis, treatment including detailed chapters on types of devices. Additionally, this report covers the overview, various treatment practices, and Hereditary Deafness forecasted epidemiology from 2018 to 2026, segmented by the seven major markets. The report also covers the market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Market Drivers:
- An upsurge in the number of ongoing clinical trials
- Rise in the prevalence of hearing loss patients
- Advancements in technological and modern sequencing technologies
Market Barriers:
- To date, existing pharmacologic therapies for genetic and acquired etiologies of deafness are severely limited
- Various gene therapy complications
- Product recalls or device issue
KOL- Views
To keep up with the market trends, we take KOLs and SME's opinion working in Hereditary Deafness domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Hereditary Deafness Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Scope of the Report
- The report covers the descriptive overview of hereditary deafness explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
- Comprehensive insight has been provided into the epidemiology of the hereditary deafness and its treatment in the 7MM
- Additionally, a complete account of both the current and emerging treatment for hereditary deafness is provided, along with the assessment of new therapies, which is likely to have an impact on the current market landscape.
- A detailed review of hereditary deafness market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global hereditary deafness market.
Report Highlights
- The report covers descriptive overview of hereditary deafness, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
- The report provides an insight into the patient population eligible for hereditary deafness in the 7MM, covering the US, EU5 (Germany, Spain, France, Italy, UK) & Japan.
- The report is a comprehensive account of marketed devices present in the hereditary deafness market.
- The report also reviews the detailed global historical and forecasted hereditary deafness market including assessing the outreach in 7MM.
- The report helps in developing business strategies by understanding trends shaping and driving the global hereditary deafness market.
Companies Mentioned
- Advanced Bionics
- Cochlear
- MED-EL GmbH
- Nurotron Biotechnology
- Oticon Medical
- Medtronic
- Envoy Medical
- Sonova
- Audina Hearing Instruments
- RION
- Decibel Therapeutics
- Frequency Therapeutics
- Pipeline Therapeutics, Inc.
Key Topics Covered:
1 Key insights
2 Report introduction
3 Executive summary of Hereditary Deafness
4 Hereditary Deafness: disease background and overview
4.1 Introduction
4.2 Disease background
4.3 Pathology
4.4 Pathophysiology
4.5 Signs and symptoms
4.6 Diagnosis
4.7 Treatment and management
5 Regulatory and reimbursement of Hereditary Deafness devices
5.1 Regulatory approval for the devices
5.1.1 United States Regulation of Devices
5.1.2 European Regulation of Devices
5.1.3 Japan Regulation of Devices
5.2 Reimbursement scenario for Hereditary Deafness devices
5.2.1 United states
5.2.2 Europe
5.2.3 Japan
6 Hereditary Deafness: marketed products
6.1 Cochlear implant
6.2 Bone Conduction Hearing Implants (BAHA)
6.3 Middle Ear Implant
6.4 Hearing Aids
7 Hereditary Deafness: Emerging Pharmacotherapies
7.1 DB-OTO: DECIBEL THERAPEUTICS
7.2 FX-322: FREQUENCY THERAPEUTICS
7.3 PIPE-505: PIPELINE THERAPEUTICS, INC.
8 Hereditary Deafness: Emerging Medical Devices
8.1 ACCLAIM COCHLEAR IMPLANT
9 Patient Journey
10 Case Reports
11 Organizations Contributing Towards Deafness
12 KOL Views
13 Assumptions And Rationale - Eligible Patient Population And Market Analysis For Hereditary Deafness
13.1 Epidemiology Assumptions
13.2 Market Outlook
14 Hereditary Deafness: 7 Major Market Epidemiology
14.1 Key Findings
14.2 7MM Total Diagnosed Prevalent Patient Population Of Hereditary Deafness
14.3 The United States
14.4 EU5
14.5 Japan
15 Hereditary Deafness: 7 Major Market Analysis
15.1 Key Findings
15.2 Market Size Of Hereditary Deafness In 7MM
15.3 United States
15.3.1 Market Size Of Hereditary Deafness In The United States
15.4 Germany
15.4.1 Market Size Of Hereditary Deafness In Germany
15.5 France
15.5.1 Market Size Of Hereditary Deafness In France
15.6 Spain
15.6.1 Market Size Of Hereditary Deafness In Spain
15.7 Italy
15.7.1 Market Size Of Hereditary Deafness In Italy
15.8 United Kingdom
15.8.1 Market Size Of Hereditary Deafness In The United Kingdom
15.9 Japan
15.9.1 Market Size Of Hereditary Deafness In Japan
16 Market Drivers
17 Market Barriers
18 SWOT Analysis
19 Unmet Needs
20 Appendix
20.1 Bibliography
20.2 Report Methodology
21 Publisher Capabilities
22 Disclaimer
23 About the Publisher
For more information about this report visit https://www.researchandmarkets.com/r/5n5y5s
